Redefining risk adjustment in ’24, delivering an ‘AI Assistant’ approach to improve accuracy, efficiency, and compliant ROI for Audit and Retrospective reviews and Prospective gap closure at point of care.

LOUISVILLE, Ky., March 14, 2024 — In an era when healthcare technology is advancing at an unprecedented pace, RAAPID is at the forefront of applying novel Neuro-Symbolic AI, revolutionizing risk adjustment coding accuracy for payers and providers. With the introduction of its AI technology, RAAPID is setting new standards reducing historical coding variation, and appropriately surfacing and suppressing suspected care gaps in both retrospective and prospective purpose-built risk adjustment solutions. This cutting-edge technology, expert in converting unstructured to structured data while converging the already structured, is clinically trained to navigate the complex landscape of clinical data while adding reasoning to ensure that RAAPID’s solutions are advanced, intuitive, and extraordinary in its efficacy.

At the heart of RAAPID’s innovation is the ability to transform vast amounts of healthcare data, where typically 70%+ is unstructured, into actionable insights. Its Neuro-Symbolic AI is a testament to the company’s commitment to leveraging technology as an AI Assistant for Coders and providers to improve accuracy and impact healthcare outcomes. This technology, embedded as an API or in RAAPID’s workflow platform, is designed to meet the customer at their state of readiness and level of efficiency. Historically, those who carry risk contracts and its typically manual and increasingly variation-prone processes provide organizational challenges with costs, compliance, and administrative burden while lacking the tools needed to ensure appropriate reimbursements and improved patient care.  RAAPID’s single platform and core technology can serve the needs for Audit, Retrospective, and the burgeoning Prospective market needs

Adding to its technological prowess, specific to its Prospective solution offering, RAAPID has entered into a strategic partnership with Holon Solutions, a leader in healthcare information technology. This partnership aims to harness RAAPID’s ability to surface suspected and emerging care gaps and along with Holon’s renowned last-mile connectivity to reduce physician administrative burden at the point of care while improving patient outcomes. Holon’s solution, partnering with RAAPID’s Neuro-Symbolic AI ensure that the right information is delivered to care teams at the right time in their workflow, enhancing decision-making and patient care.

Chetan Parikh, CEO of RAAPID, expresses immense excitement about the partnership with Holon Solutions. “This collaboration marks a significant milestone in our mission to transform healthcare through AI-driven technologies,” says Parikh. “By joining forces with Holon, we are not just innovating for the sake of technology but driving real change that benefits patients, providers, and payers alike.”

As healthcare continues to evolve, the partnership between RAAPID and Holon Solutions symbolizes a leap towards a future where technology and human-centric care converge to create a more efficient, effective, and equitable healthcare system. With mission-driven serial entrepreneurs like Chetan Parikh steering this visionary approach and investing in safe modern technology to address real challenges in segments like risk adjustment and value-based care, the healthcare industry can look forward to a future where technology truly serves – like never before – the needs of patients, payers, and providers.

Media Contact:
Mayur Vyas
(502) 498-4018
[email protected] 

About RAAPID

At RAAPID, our ambition propels us to become the world’s leading risk adjustment solutions tailored to payers, providers, and pay-viders. Dedicated to empowering these organizations to enhance their financial and member’s well-being and health while streamlining operations, RAAPID provides a comprehensive, customizable risk adjustment platform. Utilizing the forefront of technology— Neuro symbolic AI(AI), deep learning, clinically-trained natural language processing (NLP), and intricate knowledge graphs—our platform is engineered to unlock profound insights and drive precision in risk adjustment technology.

About Holon Solutions: Holon Solutions is the leading human-centric healthcare technology company that provides relief to healthcare teams. Our intelligent platform is a place where healthcare administration becomes effortless, with personalized tools that eliminate complexity. Using patented sensor technology, we deliver key information at the point of care to help save time, improve health outcomes, and increase revenue, with robust analytics that demonstrate value for enterprises.

SOURCE RAAPID

Drop-on-demand technology will enable sustainable, production-grade additive manufacturing using high-value metal components

CAMBRIDGE, Mass., March 14, 2024 — Fluent Metal is developing production-grade liquid metal printing to remove barriers to entry into metal additive manufacturing, while allowing for unmatched scalability and process tunability. Today, the company is launching out of stealth with an additional $3.2M in venture capital funding, led by E15 with participation from Pillar VC and industry angels, bringing the total funding to $5.5M. Fluent Metal’s drop-on-demand approach is compatible with most metals, including refractories, and enables the creation of parts in a single-step process, minimizing variability. It is energy efficient: using less starting material and producing no waste–making it far more sustainable than current powder-based metal 3D printers.

“Drop-on-demand technology is an elegant approach to create complex metal components,” said Peter Schmitt, CEO. “Whether it’s prototype iterations of an idea or production runs of a single part, Fluent Metal will provide customers with great operational and material flexibility. This freedom will unlock new creativity and problem solving abilities across industries.”

Existing metal additive manufacturing technology has come to accept the extensive industrial scale overhead required to operate this equipment safely. Fluent Metal is developing an alternative lean overhead process, to make it more sustainable, operational efficient and functional, using an inkjet printer-like approach.

Fluent Metal’s drop-on-demand approach is:

• Functional: Using wire as the starting material and producing no waste, Fluent Metal enables true multi-metal printing. It’s possible for even high-value metals to be intricately combined; creating properties never before possible. Complex shapes such as fully enclosed voids and internal channels are possible due to the inkjet-like printhead and parallel throughput.
• Operationally efficient: Fluent Metal’s approach is designed to operate safely on a typical manufacturing floor or even in a prototyping shop, without the need for clean rooms or expensive safety measures. Additionally, material changeover is designed to be easy as plug-n-play, reducing setup efforts and allowing for higher machine uptimes.
• Sustainable: This approach produces no waste and uses less energy than powder-based technologies.

“As the manufacturing industry evolves in response to the changing needs of global supply chains and sustainability demands, we need novel approaches to drive creativity and expand our collective conception about what’s possible,” said Philip Liang, Managing Partner, E15. “In the near term, Fluent Metal will spark the imagination of designers, engineers, and technologists to consider how rapid, on-demand production of custom metal parts could transform their capabilities. At scale, this approach will revolutionize the entire footprint and direction of industrial manufacturing.”

Fluent Metal is led by industry veterans from Desktop Metal, Vulcan Forms, and the MIT Media Lab. Visit www.fluentmetal.com to learn more about contract manufacturing and be the first to know about expanded product offerings.

Contact information 
Mario Terceros Arce
[email protected]
‪(617) 468-8243

SOURCE Fluent Metal

Inspiring New Generations of Leaders and Teams to Work Hard, Smart and Together.

CHAPEL HILL, N.C., March 14, 2024 — The leadership lessons from The New York Times best-selling book The Carolina Way live on 20 years after its original publication in 2004. During this March tournament season, the Bell Leadership Institute will continue to spread the timeless principles of The Carolina Way. Throughout the month of March, Bell Leadership will highlight ways leaders can inspire their teams to “work hard, smart, and together” through a series of dedicated articles that demonstrate how to grow their impact and embrace their roles as key leaders within their organizations.

“The most successful leaders behave in ways that cause three major results: they cause people (1) to work hard, (2) to work smart, and (3) to work together. In this way, they create success.”
– Dr. Gerald D. Bell
Founder & CEO, Bell Leadership Institute

In the approachable and engaging narrative of The Carolina Way, the late Dean Smith, former University of North Carolina Head Men’s Basketball Coach, explains the philosophy and strategy that led him to become one of the most successful coaches of all time. Co-author Dr. Gerald D. Bell, a highly regarded leadership expert and founder of the Bell Leadership Institute, translates these lessons from the court into actions for business leaders that can quickly be put into practice. Through Coach Smith’s leadership, his teams grew to embody his principle of “play hard, smart, and together.” Dr. Bell leverages his professional wisdom to help business leaders “work hard, smart, and together.”

Dr. Bell and the Bell Leadership Institute he founded in 1972 remain steadfast in their mission to build leaders and strengthen organizations across the globe. Through his principles and research, the Bell Leadership Institute has helped to develop the skills of more than 500,000 leaders world-wide. Lessons from The Carolina Way are embedded in the DNA of Bell Leadership and its teachings. Decades after Coach Smith’s tenure at UNC, Bell Leadership Institute continues to make sure great teams are developed and strengthened in Chapel Hill and throughout the world by providing executive education and assessments to build individuals and organizations to be their best, solving today’s challenges and capturing future opportunities.

Follow the March 2024 series of articles by visiting Bell Leadership online where you can learn more about applying the principles of The Carolina Way to your business, as well as access other helpful resources.

About Bell Leadership Institute Bell Leadership Institute is a recognized leader in executive education and leadership training. Since 1972, Bell Leadership has helped individuals and organizations develop leadership mastery through its leadership solutions, programs and services. Anchored by the Bell Achiever Model™, the Bell Leadership Mastery Series™ comprises eight essential topics that are the building blocks of effective leadership. This comprehensive suite of seminars and proprietary assessment tools draw from over 50 years of research and consultation with thousands of CEOs and senior leaders. Learn about Bell Leadership Trainers, Speakers and Coaches and Bell Leadership solutions at www.bellleadership.com, or connect on LinkedIn.

Company:        Bell Leadership Institute
Contact:           Laura Levin                                   
Telephone:       845-500-5598
Email:              [email protected]

SOURCE Bell Leadership Institute

SINGAPORE, March 14, 2024 — Polyhedra Network, the team behind zero-knowledge interoperability protocol zkBridge, today announced the closing of a $20 million strategic funding round, valuing the company at $1 billion USD. The round is led by Polychain Capital, with participation from Animoca Brands, Emirates Consortium, Mapleblock Capital, Hashkey Capital, UoB Ventures, Symbolic Capital, Longhash Ventures, MH Ventures, Arkstream Capital, and Web3Port Foundation, among others. This is the fifth round of financing conducted by Polyhedra Network over the past two years. 

Polyhedra Network is an infrastructure company that utilizes zero-knowledge proofs as the foundation of its products, providing users with improved security, scalability, and trust-minimization. In the case of zkBridge, unforgeable zero-knowledge proofs are used to validate the state and consensus of the sender chain, which is then verified on the destination. To date, zkBridge has secured over 20 million cross-chain transactions between the 25+ blockchains it connects, which includes millions of messages sent using the LayerZero protocol.

The funds from this round will play an integral role in escalating Polyhedra Network’s continued growth by increasing the network’s employee base and exploring further global expansion. This expansion will allow Polyhedra Network to further cement its presence as the premier zero-knowledge institution and globally promote the adoption of trust-minimized interoperability.

Eric Vreeland, Chief Strategy Officer of Polyhedra Network, commented: “Blockchains were not architected in a way to efficiently process large amounts of computation and information. With the advancements we’ve made in the zero-knowledge proof space, we are no longer beholden to the speed and cost constraints that are slowing adoption. We continue to push the envelope in terms of what is possible, for example, proving the entire Ethereum consensus in under 8 seconds. With our ZK technology, developers no longer have to choose between performance and ease-of-use.”

The founding team, who met while studying cryptography and finishing their respective Ph.D. programs, quickly realized that zero-knowledge proofs offer a way to share information between networks that align with blockchain’s core ethos of decentralization. Since its founding, members of the Polyhedra Network team have authored over a dozen academic papers with findings that improve the performance of zero-knowledge proofs and open up applications previously thought impossible. Recently, the team announced its intention to create an interoperability protocol between the Bitcoin and Ethereum ecosystems, an arduous task not yet conquered by the industry given Bitcoin‘s lack of smart-contract functionality.

Vreeland concluded: “Blockchain technology is revolutionary because it allows for individuals and institutions to transact without a trusted intermediary. As blockchain usage continues to grow, technology that enables secure and highly scalable computation across multiple networks will be a necessity. Unlocking this without introducing additional trust assumptions is critical if we are to stay true to the values this industry was founded on. Zero-knowledge technology is the key to unlocking blockchain’s full potential.”

Investor Quotes: 

Polychain Capital

“Polyhedra Network stands at the forefront of Web3 innovation. Their focus on trust-minimized interoperability and scalability using Zero-knowledge proof technology sets them apart and we believe they are not just creating infrastructure but architecting a more efficient and unified Web3. We are thrilled to support Polyhedra in their new round as they continue to shape the crypto landscape.” Luke Pearson, General Partner at Polychain Capital.

About Polyhedra Network

Polyhedra Network is building the next generation of secure, interoperable, and scalable Web3 infrastructure with advanced zero-knowledge proof technology. The team has developed and deployed several next-generation zk-SNARK protocols resulting in performance improvements orders of magnitude faster than existing solutions. Their interoperability solution, zkBridge, connects over 25 blockchains and proves the validity of cross-chain messages utilizing zero-knowledge proofs. Developers building with Polyhedra Network can create secure, scalable, interoperable applications without any additional trust assumptions.

For more information visit: https://polyhedra.network

Media Contact
M Group Strategic Communications (on behalf of Polyhedra Network)

SOURCE Polyhedra Network

SquareDash empowers roofing and restoration companies to streamline their operations with its managed billing services and to get paid the same day they finish the work on approved property insurance claims.

FORT WORTH, Texas, March 14, 2024 — SquareDash, the top payment advance platform in the property insurance restoration industry, today announced it has raised over $20 million in total financing to accelerate growth. The latest equity round, led by FINTOP Capital, builds on SquareDash’s previous equity raise in mid-2023 with participation from Hivers and Strivers, The PenFed Foundation, i2BF Global, The Hustle Fund, The Council and other angel investors. The company also secured a $15 million credit facility that can expand to $25 million as needed. The funds will be used to expand the company’s payment advance and subscription services, grow the team, and invest in sales and marketing.

Founded in 2022 by U.S. Navy veteran Matt Fruge after successfully running a roofing company for over 10 years, SquareDash offers both claim funding and a subscription service to manage the billing, payment, and collections process. This empowers roofers and restorationists, especially those in the $2 million to $15 million revenue range, to overcome insurance claim challenges and get paid the same day they finish work.

“As a former roofer myself, I know firsthand the cash flow challenges faced by roofing and restoration businesses,” said CEO and Founder of SquareDash Matt Fruge. “With this latest funding, we’ll be able to help even more of these entrepreneurs get paid faster for their hard work and grow successful businesses. I’m grateful for the support of FINTOP Capital, PenFed Foundation, and all our investors who share our mission.”

“SquareDash is tackling a huge market inefficiency and empowering restoration professionals to control their cash flow and expand their businesses,” said Partner at FINTOP Capital John Philpott. “Matt and the team have built an innovative platform, and we’re excited to support their growth as they transform payments in the roofing industry.”

SquareDash was selected to participate in The PenFed Foundation Veteran Entrepreneur Program Fall 2022 Cohort. The program exclusively supports veteran and military spouse entrepreneurs building highly scalable startup companies — ranging from the idea stage through to Series A and beyond.

“It’s been a privilege to support Matt and SquareDash through our Veteran Entrepreneur Program,” said PenFed Foundation President Andrea McCarren. “As a veteran-led company solving real challenges for roofing businesses, it is a prime example of the innovative startups we seek to elevate. This funding is a testament to the strength of their vision and execution.”

For more information about SquareDash visit https://squaredash.com.

About SquareDash
SquareDash is on a mission to empower roofing and restoration companies to overcome insurance claim challenges and get paid the same day they finish the work. SquareDash offers both claim funding and a subscription service to manage the administration through the billing, payment and collections process.

About FINTOP Capital
FINTOP Capital is a venture capital firm focused on early-stage FinTech companies. With over $700 million in committed capital across five funds, FINTOP brings decades of FinTech founding and operating experience to the board room, partnering with innovative entrepreneurs to push the frontiers of the financial services sector.
www.fintopcapital.com

About PenFed Foundation
Founded in 2001, The PenFed Foundation is a national nonprofit organization that supports veterans in their transition from service to success. Affiliated with PenFed Credit Union, the Foundation has provided more than $50 million in financial support to veterans, active-duty service members and military families. The credit union funds the Foundation’s personnel and most operational costs, allowing 99% of incoming donations to go directly to our programs. To learn more, please visit www.penfedfoundation.org.

SOURCE PenFed Foundation

SINGAPORE, March 14, 2024 — OKX Ventures, the investment arm of OKX, the world’s leading cryptocurrency exchange and Web3 technology company, is proud to announce its investment in DLC.Link, the first native Bitcoin cross-chain protocol that leverages Discreet Log Contracts (DLCs) to enable Bitcoin to be used in DeFi protocols while being held in self-custody wallets.

DLC.Link is a groundbreaking project that aims to bring the power and innovation of DeFi to the Bitcoin ecosystem without compromising on security, decentralization or user experience. DLC.Link partners with institutions (called “dlcBTC Merchants”)  to mint dlcBTC, a decentralized wrapped Bitcoin. Unlike other forms of wrapped Bitcoin, dlcBTC does not require Bitcoin deposits to be held with a custodian or bridged to a separate blockchain.

To mint dlcBTC, Bitcoin depositors “self-wrap” by locking their collateral into a DLC which can only pay out to the original depositor. Thus, dlcBTC provides a “theft-proof” protocol, in that Bitcoin deposits cannot be lost through hacks, theft or fraud. Furthermore, since only the original depositor can retrieve funds, dlcBTC is more resistant to censorship than current forms of wrapped Bitcoin.

Unlike Bitcoin L2s or sidechains, which require additional modifications to Bitcoin, support for DLCs was added in Bitcoin‘s Taproot upgrade. This means that DLCs can leverage the security, liquidity and network effects of Bitcoin, while bridging to DeFi protocols on Ethereum without requiring separate validator nodes. Instead, DLC.Link provides a network of DLC Attestors running Ethereum validators, provided by popular node operators such as OKX, HashKey Cloud, Republic, P2P, Dextrac and others.

Aki Balogh, co-founder of DLC.Link, said: “wBTC has reached Top 15 token status, despite its centralized custody model. In contrast, dlcBTC is the only wrapped Bitcoin that is minted from self-custody. DLCs, which were added to Bitcoin in 2021, enable a theft-proof wrapping mechanism without the need to introduce a bridge or L2 chain. dlcBTC will boost the adoption of Bitcoin in DeFi and has the potential to become a Top 10 token.”

Dora Yue, founder of OKX Ventures, said: “DLC.Link is a pioneering project aimed at bringing the power and innovation of DeFi to the Bitcoin ecosystem, without compromising security, decentralization, or user experience. We are pleased to support the vision and mission of DLC.Link. OKX Ventures believes that DLC.Link will unlock more value and potential within Bitcoin, and create a more open, inclusive, and decentralized financial system.”

To learn more about DLC.Link, click here.

For further information, please contact:
[email protected] 

About OKX Ventures
OKX Ventures is the investment arm of leading crypto exchange and Web3 technology company OKX, with an initial capital commitment of USD 100 million. It focuses on exploring the best blockchain projects on a global scale, supporting cutting-edge blockchain technology innovation, promoting the healthy development of the global blockchain industry, and investing in long-term structural value.

Through its commitment to supporting entrepreneurs who contribute to the development of the blockchain industry, OKX Ventures helps build innovative companies and brings global resources and historical experience to blockchain projects.

Find out more about OKX Ventures here.

Disclaimer

About DLC.Link

DLC.Link harnesses the power of Discreet Log Contracts (DLCs) to establish a trustless bridge between Bitcoin and Ethereum. This spring, DLC.Link will launch dlcBTC, enabling depositors to self-wrap their Bitcoin for DeFi on Ethereum while retaining full custody of their assets. This innovation transforms Bitcoin‘s role in DeFi, empowering depositors to engage in trading, lending, and hedging while maintaining self-sovereignty.

For more details, visit www.dlc.link

SOURCE OKX Ventures

-Gayatri Sarkar, fundadora y consejera delegada de Advaita Capital, nombrada patrocinadora heredera de la Princess Grace Foundation

BOSTON, 13 de marzo de 2024 — Advaita Capital, una firma de capital de riesgo en crecimiento que se especializa en inversiones en tecnología profunda y descarbonización, anuncia con orgullo que su fundadora y consejera delegada, Gayatri Sarkar, ha sido nombrada patrocinadora principal de la prestigiosa Princess Grace Foundation de EE.UU. Supervisada por Su Alteza Serenísima el Príncipe Alberto II de Mónaco (hijo de la Princesa Grace), la Princess Grace Foundation -EE.UU. se dedica a elevar a artistas de extraordinaria promesa en teatro, danza y cine a través de subvenciones innovadoras.

Este estimado reconocimiento destaca el compromiso de Sarkar con la filantropía, el mecenazgo y sus extraordinarios logros en los negocios y las finanzas. Gayatri Sarkar se une al estimado grupo de patrocinadores de la corona solo invitados que incluye al inversionista de capital privado y multimillonario John Paulson, inversionista de capital privado y secretario de la Marina durante la administración Reagan, John Francis Lehman, director de “Crazy Rich Asians”, Jon M. Chu, la socialité, filántropa y heredera editorial estadounidense Anne Hearst McInerney, la multimillonaria Lady Tina Green, directora de Taveta, propietaria mayoritaria de Taveta Investments Ltd, la empresa matriz del Grupo Arcadia, el actor y cantante Leslie Odom Jr. y algunos otros dignatarios conocidos mundialmente.

Sarkar declaró, “Es verdaderamente un honor unirme a una lista tan exitosa de patrocinadores dedicados a fomentar la creatividad y la excelencia entre los artistas emergentes. Espero trabajar estrechamente con la fundación para ampliar su alcance e impacto entre los talentos que lo merecen”.

Sarkar aporta una gran experiencia y logros como patrocinadora de la corona. Su experiencia abarca las industrias de tecnología y finanzas, comenzó su carrera técnica en Hewlett Packard, IBM y posteriormente en Goldman Sachs y luego trabajó en el Banco de la Reserva Federal gestionando activos de proyectos del Tesoro de EE.UU. en el ejército y la Marina de EE.UU. También es una emprendedora en serie y anteriormente fundó dos nuevas empresas. Fue nombrada líder global menor de 40 años por su defensa de género presentando administradores de activos institucionales en inversiones de capital de riesgo a través de su podcast She-VC.

Advaita Capital es una empresa de capital de riesgo en crecimiento, propiedad 100% de mujeres POC. Advaita Capital cuenta con un equipo de doctores de Harvard, doctorados del MIT, estudiantes universitarios de Yale, ingenieros de Wharton y ex directores de operaciones de grandes empresas de gestión de activos. Al aprovechar un amplio conocimiento de la industria, Advaita Capital invierte entre 10 y 50 millones de dólares o más, apoyando a empresas emergentes extremadamente atípicas y a emprendedores visionarios. Las áreas de inversión abarcan la IA generativa, los semiconductores, la robótica, el almacenamiento de energía y la infraestructura de descarbonización a gran escala. Entre las empresas de cartera de alto perfil de Advaita Capital se encuentran Stripe, Epic Games, Cohere y Neuralink, lo que ilustra el buen ojo de la empresa para la innovación y el potencial transformador.

Foto – https://mma.prnewswire.com/media/2361864/Advaita_Capital.jpg
Logo – https://mma.prnewswire.com/media/2361936/Advaita_Capital_Logo.jpg

DUBENDORF, Switzerland , March 13, 2024 — Odne Ltd, a Swiss dental start-up company and upcoming innovator in endodontic treatments, is pleased to announce the closing of its Series A1 Financing Round raising USD 5.5 million (CHF 4.8 million) to fund the upcoming US market launch. Odne’s game-changing technology platform for Root Preservation Therapy (RPT) is expected to transform endodontics. The Odne RPT workflow introduces three new medical devices enabling minimal invasive root canal cleaning and light-cured obturation. 

The Series A1 round is led by Revere Partner (NY), an independent venture fund providing capital for cutting-edge innovations in oral and systemic health, and NV Capital (LIE), a family-owned venture capital boutique. Alongside the lead investors several other renowned funds such as Dental Innovation Alliance (DIA), Plug&Play, Hatcher, Züricher Kantonalbank, as well as various family offices and angel investors are backing Odne`s US market launch.

“With over 15 million root canal treatments per year, the US is the biggest market worldwide and our number one focus. Currently, we are performing a Priority Access Program to deepen the use of our products with selected US key opinion leaders. At the annual meeting of the American Association of Endodontists (AAE) in April, in Los Angeles, we will introduce the Odne RPT workflow solution to the endodontic community,” states Dr. Andreas Schmocker, CEO & Co-Founder, Onde.  

“Odne is within the core investment focus of Revere Partners: innovations in oral health. After receiving FDA clearance for Odne™Cure and Odne™Fill in 2023 the series A1 financing fuels Odne`s US market launch to the endodontic community. Together with all investors, Revere Partners is proud to elevate Odne`s RPT workflow for the benefit of patients, endodontists, and the referring general dentists,” adds Dr. Jeremy Krell, Managing Partner, Revere Partners.  

To serve the US endo specialist market, Odne has recently founded Odne Inc, USA. The team of Odne is evolving, incorporating experienced and well-connected dental experts, building training, service, marketing, and sales.

About Odne

Odne (Onde Ltd and Odne Inc) is a Swiss-US dental startup. that has its roots in a groundbreaking collaboration between two renowned universities: the Swiss Federal Institutes of Technology in Lausanne and Zürich (EPFL & ETH Zürich). Founded in 2018, Odne`s journey began by licensing cutting-edge technology assets from these esteemed institutes.

Odne represents a harmonious synergy of Swiss precision and academic excellence. Our company is committed to pioneering the future of endodontics through advanced technology and innovative solutions. Endodontics, the field of dental medicine that deals with root canal treatments, has been marred by complexity and unpredictability. Odne AG is on a mission to change that.

Root canal treatments have long posed challenges for dentists, with traditionally low success rates ranging from 46% to 91%. With over 60 million annual treatments worldwide, these failures result in significant healthcare costs.

Odne’s technology platform addresses these issues by offering treatment options for both, dentists and their patients. Our products, slated for launch in 2024, tackle problems such as debridement and obturation in complex root canal morphologies.

About Revere Partners

Revere Partners is the first and only venture capital fund globally focused on investing in oral health technology. Revere invests in cutting-edge and innovative dental technology companies that improve the lives of dental patients and providers through advancements in science and technology. Revere Partners invites new accredited investors to join the fund and enables startups to connect with unrivaled industry resources and growth opportunities. Founded by Dr. Jeremy Krell and David Arena, Revere Partners fosters strategic partnerships that improve care delivery as well as patient and provider experiences – maximizing value for investors. To learn more visit www.reverepartnersvc.com or on LinkedIn.

About NV Captial

N & V Capital is a family-owned venture capital boutique focused on European investments in various sectors such as Fintech, MedTech, and Digital Health. With generations of entrepreneurial experience, N & V seeks scalable ventures driven by technology or scientific progress. The boutique brings its own entrepreneurial experience to the table and offers its extensive network and expertise to visionary founders seeking sustainable growth for their companies. Although N & V Capital invests up to Series A, the main focus is on early-stage investments.

Disclaimer: Odne™Fill and Odne™Cure are cleared for use in the U.S.A only. All other Odne devices are currently in development and have not received clinical approval in any jurisdiction.

Odne`s technology platform for root canal debridement and obturation including: the first hydro-dynamic cavitation device using saline as main debridement medium, and the first FDA cleared highly flowable, light-cured obturation material.

For further information contact: 
Holger Essig, General Manager / Head of Global Marketing
Odne AG, Ringstrasse 14, 8600 Dübendorf, Switzerland
[email protected]
www.odne.co

SOURCE Odne Inc.

Oversubscribed round propels company towards clinical trials and global market expansion, promising to extend organ preservation times and revolutionize healthcare.

SAN FRANCISCO, March 13, 2024 — X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has completed an oversubscribed $22.4 million Series B funding round. The investment enables X-Therma to scale global commercial operations and facilitates the company’s progression into the clinical stage with Food and Drug Administration (FDA) Breakthrough Device status, aimed at significantly increasing organ availability for transplantation by overcoming time-sensitive limitations.

The investment will advance multiple key products in X-Therma’s development pipeline: XT-Thrive® and XT-NoVo^TM for regenerative medicine and cell therapy and XT-ViVo® & TimeSeal® for organ preservation for transplantation. XT-ViVo® & TimeSeal® received FDA Breakthrough Device designation, which is given to products that have the potential to offer more effective diagnosis or treatment of life-threatening diseases with an unmet medical need.

“This funding marks a pivotal moment as we prepare to launch our GMP-grade cryopreservation and cold-chain solutions into the commercial market, responding to growing demand in Cell and Gene Therapy and bioprocessing,” says Dr. Xiaoxi Wei, Ph.D., Co-founder and Chief Executive Officer of X-Therma. “It also propels us to the forefront of organ transplantation innovation, with our emerging products that could eliminate time as a critical constraint, with the potential to save millions of lives.”

“Designed as a foundational building block for living medicines, our platform promises to accelerate the development of tailored solutions for critical health care challenges and next-generation treatments,” continues Dr. Wei.

The round was co-led by new investor Starling Locke Capital, fully supported by Series A lead investor, LOREA AG, along with participation from new and existing investors.

“Despite the capital winter challenging the life sciences sector, X-Therma stands out with its exceptional resilience and potential. Finalizing its second oversubscribed round, X-Therma has clearly demonstrated its compelling value to investors and the health care ecosystem,” says Johannes Weggemann, Managing Director at LOREA AG.

“I’ve witnessed firsthand the evolution of biotech,” says the Hon. Jim Greenwood, who represented Pennsylvania’s Eighth Congressional District from 1993-2005, and served as President and CEO of the Biotechnology Innovation Organization (BIO) for 17 years. “As a member of X-Therma’s board and an investor myself, I’m confident X-Therma is poised to revolutionize organ transplantation and regenerative medicine.”

“The market’s response validates our belief in X-Therma’s technologies and their potential to revolutionize not only organ transplantation, but also to extend global organ sharing beyond what was once deemed possible,” concludes Dr. Wei. “We are ready to get our products to customers and patients and begin getting more organs to patients around the globe. You have time.”

XT-Thrive®: Advancing Regenerative Medicine and Cell Therapy
X-Therma’s XT-Thrive® enables non-toxic cryopreservation for life-saving regenerative medicines such as vaccines, cell and gene therapies, and engineered tissues. XT-Thrive® is a DMSO-free, serum-free, protein-free, and chemically defined cryopreservation media for the preservation of mammalian cells at ultra-low temperatures (-70° C to -196° C). Designed and manufactured with the utmost quality in mind, XT-Thrive® is tailored to provide high cell recovery and functionality. It is a non-toxic and hyper-effective alternative to traditional cryopreservatives and is plug and play for cell and tissue manufacturing processes.

XT-NoVo^TM & TimeSeal®: A Turnkey Solution for Regenerative Medicine
X-Therma’s XT-NoVo^TM non-toxic, serum- and protein-free preservation solution and TimeSeal® smart sensor tissue and cell transporter allow for a significant extension in shelf-life of precious cell-based starting materials and finalized products at sub-zero temperatures at -5°C without freezing. Biologics can be stored for up to 7 days, even certain sensitive cell types that usually exhibit a 1–2-day shelf life. This can alleviate the burden to coordinate rapid shipping of products and open the path for a cost-effective cold chain. TimeSeal® contains integrated and intelligent sensor technology that transmits real-time data not limited to temperature and location of the shipped biologics. No extras such as blood, oxygen, or external power supply are required.

XT-ViVo® & TimeSeal®: Setting New Standards in Organ Transplantation
X-Therma’s XT-ViVo® organ preservation solution and TimeSeal® Organ Transport Device could enable multi-day preservation to remove time from the equation using static storage and tried and true techniques well-practiced by every surgeon. This solution prevents damaging ice crystal formation during organ preservation at subzero temperature while supporting reduced metabolism and reduced ischemic damage to the organ. TimeSeal® is a smart, portable, and easy-to-use transporter to safely and consistently transport organs. With its smart sensor technology, the organ can be tracked during transport with optimum temperature stability. TimeSeal® doesn’t require any external power, perfusion, oxygen, or blood to keep the organs and tissues alive. The FDA designated XT-ViVo® & TimeSeal® Breakthrough Device Designation for an intended kidney preservation and storage time of up to 120 hours. The products also have the potential to be used in other organ and tissue applications.

About X-Therma Inc.
X-Therma Inc. is pioneering breakthrough cold chain technology via a convergent biopreservation platform, to advance regenerative medicine and make available safe and on-demand organs, engineered tissues, cell and gene therapies, vaccines, and beyond to patients in need. Headquartered in Hercules, part of the San Francisco Bay Area and an expanding presence in Austria, X-Therma’s technology is poised to become a paradigm shift that enables worldwide organ sharing and eliminates organ waiting lists across the globe.

For press inquiries, please contact:
[email protected]

SOURCE X-Therma Inc.